Olympus Corporation (7733.T)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Robert John White
|
Representative Executive Officer, President, CEO & Director | 731M | -- | 1962 |
|
Mr. Syed Mukarram Naveed
|
Executive Officer & CTO | 302M | -- | 1973 |
|
Mr. Neil Boyden Tanner
|
Executive Officer & Global General Counsel | 298M | -- | 1971 |
|
Mr. Frank Drewalowski
|
Senior Advisor to Chief Executive Officer | 994M | -- | 1965 |
|
Ms. Gabriela Castillo Kaynor
|
Executive Officer, Chief Strategy Officer & ESG Officer | 265M | -- | 1975 |
|
Mr. John Manfred de Csepel
|
Executive Officer & Chief Medical Officer | 291M | -- | 1964 |
|
Mr. Michael Angelo Parenti
|
CFO & Executive Officer | -- | -- | 1977 |
|
Takayuki Aoyagi
|
Vice President of Accounting | -- | -- | -- |
|
Stephen Kneebone
|
Corporate Officer & Chief Information Officer | 734M | -- | -- |
|
Mr. Takaaki Sakurai
|
Vice President of Investor Relations | -- | -- | -- |
Olympus Corporation
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 28,138
Description
Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
Corporate Governance
Upcoming Events
November 10, 2026 at 6:30 AM UTC
Olympus Corporation Earnings Date
March 30, 2027 at 12:00 AM UTC
Ex-Dividend Date
Recent Events
Recent Events Information Not Available
